0RIS.L
CIRCIO HOLDING ASA CIRCIO HOLDI
£8.94
+3.41%
2026-05-29
About CIRCIO HOLDING ASA CIRCIO HOLDI
Circio Holding ASA, a biotechnology company, develops novel circular RNA expression technology for gene and cell therapy. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in human cells. It has a research collaboration with United Immunity Co., Ltd. for the development of vivo CAR-Macrophage (CAR-M) therapy. The company was formerly known as Targovax ASA and changed its name to Circio Holding ASA in May 2023. Circio Holding ASA was incorporated in 2010 and is based in Oslo, Norway.
Key Fundamentals
EPS (TTM)
£-0.93
Profit Margin
0.0%
Price/Book
-102.76
Beta
-1.23
Market Cap
£515.7M
Avg Volume (10D)
3K
Recent Breakout Signals
No recent breakout signals detected for 0RIS.L.
Recent Price Range (60 Days)
60D High
£14.12
60D Low
£2.31
Avg Volume
70K
Latest Close
£8.94
Get breakout alerts for 0RIS.L
Sign up for Breakout Scanner to receive daily notifications when 0RIS.L triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
CIRCIO HOLDING ASA CIRCIO HOLDI (0RIS.L) is listed on the London Stock Exchange (LSE). Breakout Scanner monitors 0RIS.L daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups.. Data is provided for informational purposes only and does not constitute financial advice.